.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020468

« Back to Dashboard
NDA 020468 describes NASACORT ALLERGY 24 HOUR, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from three suppliers. There are three patents protecting this drug. Additional details are available on the NASACORT ALLERGY 24 HOUR profile page.

The generic ingredient in NASACORT ALLERGY 24 HOUR is triamcinolone acetonide. There are forty-nine drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Suppliers and Packaging for NDA: 020468

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL 020468 NDA sanofi-aventis U.S. LLC 0075-1506 0075-1506-16 120 SPRAY, METERED in 1 BOTTLE, SPRAY (0075-1506-16)
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL 020468 NDA AUTHORIZED GENERIC Winthrop U.S. 0955-1710 0955-1710-16 120 SPRAY, METERED in 1 BOTTLE, SPRAY (0955-1710-16)

Summary for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SPRAY, METERED;NASALStrength0.055MG/SPRAY
Approval Date:Oct 11, 2013TE:RLD:Yes
Patent:5,976,573Patent Expiration:Jul 3, 2016Product Flag?YSubstance Flag?Delist Request?
Patent:6,143,329Patent Expiration:Jul 3, 2016Product Flag?YSubstance Flag?Delist Request?
Patent:7,977,045Patent Expiration:Jul 3, 2016Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 020468

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL020468-002Oct 11, 20135,976,573► subscribe
Sanofi Aventis Us
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL020468-002Oct 11, 20137,977,045► subscribe
Sanofi Aventis Us
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL020468-002Oct 11, 20136,143,329► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc